A number of events may occur in 2010 that could have a long-term effect on the pharmaceutical market. These include the potential for passage of comprehensive healthcare reform in the United States, as well as legislative or regulatory actions in other countries, and the timing and extent of the global economic recovery.
Looking back to the varying changes and pressures the industry has endured, and ahead to how the industry will need to reinvent itself to continue to prosper, companies are adapting to longer-term marketplace trends and evolving patient needs.
The industry is facing pressure from the economic, regulatory, and R&D environments. The industry’s movement toward transformation in business models, marketing strategies, and R&D processes is a sign that difficult times are upon us.
According to Rich Fante, president of AstraZeneca US, the business environment is driving the greatest era…
IMS Health — Key Market Dynamics